Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Post Marketing Surveillance Study to Observe Safety and Effectiveness of Zavicefta IV

NCT05733104 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05733104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05733104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Post Marketing Surveillance Study to Observe Safety and Effectiveness of Zavicefta IV
Lead sponsor
Pfizer
Phase
Observational
Overall status
Recruiting
Start date
February 19, 2024
Completion date
September 28, 2029
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complicated intra-abdominal infection, complicated urinary tract infection, hospital-acquired pneumonia